UNICA IRIS Institutional Research Information System

DEL ZOMPO, MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 273.302
NA - Nord America 14.116
AS - Asia 4.390
SA - Sud America 844
AF - Africa 95
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 10
Totale 292.774
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 268.742
US - Stati Uniti d'America 13.968
CN - Cina 2.002
SG - Singapore 1.562
NL - Olanda 1.088
UA - Ucraina 1.015
SE - Svezia 765
BR - Brasile 725
DE - Germania 559
GB - Regno Unito 389
FI - Finlandia 353
VN - Vietnam 271
IN - India 126
FR - Francia 123
KR - Corea 107
CA - Canada 79
HK - Hong Kong 72
RU - Federazione Russa 51
MX - Messico 50
AR - Argentina 40
PL - Polonia 38
AT - Austria 37
BD - Bangladesh 35
BE - Belgio 34
ZA - Sudafrica 34
ES - Italia 27
JP - Giappone 27
TR - Turchia 26
EC - Ecuador 25
ID - Indonesia 23
IQ - Iraq 20
AU - Australia 16
EG - Egitto 16
CO - Colombia 15
PK - Pakistan 14
UZ - Uzbekistan 14
MA - Marocco 13
IE - Irlanda 12
IL - Israele 12
CZ - Repubblica Ceca 11
EU - Europa 10
IR - Iran 9
JO - Giordania 9
VE - Venezuela 9
AZ - Azerbaigian 7
CL - Cile 7
KE - Kenya 7
KZ - Kazakistan 7
MU - Mauritius 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
BG - Bulgaria 6
BO - Bolivia 6
GR - Grecia 6
LT - Lituania 6
PH - Filippine 6
PT - Portogallo 6
PY - Paraguay 6
SA - Arabia Saudita 6
UY - Uruguay 6
DO - Repubblica Dominicana 5
RO - Romania 5
CH - Svizzera 4
DK - Danimarca 4
DZ - Algeria 4
KG - Kirghizistan 4
NP - Nepal 4
PE - Perù 4
RS - Serbia 4
TW - Taiwan 4
AL - Albania 3
MY - Malesia 3
NG - Nigeria 3
NO - Norvegia 3
QA - Qatar 3
BA - Bosnia-Erzegovina 2
GE - Georgia 2
HN - Honduras 2
HU - Ungheria 2
JM - Giamaica 2
KW - Kuwait 2
MK - Macedonia 2
OM - Oman 2
PA - Panama 2
PR - Porto Rico 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
IS - Islanda 1
KN - Saint Kitts e Nevis 1
LB - Libano 1
LC - Santa Lucia 1
LU - Lussemburgo 1
MD - Moldavia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
Totale 292.767
Salva come PNG Salva come JPEG
Città #
Cagliari 263.466
Uta 4.583
Fairfield 1.669
Ashburn 1.197
Woodbridge 1.165
Amsterdam 1.068
Chandler 1.012
Houston 883
Singapore 721
Dallas 688
Seattle 658
Wilmington 653
Boardman 643
Ann Arbor 640
Cambridge 532
Jacksonville 518
Nyköping 472
Beijing 385
Dearborn 256
New York 209
Hefei 200
Los Angeles 197
Helsinki 180
Nanjing 179
Santa Clara 178
Boston 165
Shanghai 132
Munich 112
Buffalo 109
Seoul 106
The Dalles 101
San Diego 90
Ho Chi Minh City 72
Shenyang 71
Redwood City 69
Hong Kong 65
Dong Ket 64
Nanchang 61
Hangzhou 59
Atlanta 58
Milan 58
Jiaxing 52
Mountain View 51
Norwalk 50
São Paulo 49
London 45
Verona 45
Changsha 44
Hebei 44
Hanoi 43
Guangzhou 41
Rome 39
Tianjin 38
Redondo Beach 37
Pune 35
Brussels 34
Jinan 34
Chicago 33
Warsaw 33
Montreal 30
Rio de Janeiro 30
Toronto 30
Frankfurt am Main 29
Council Bluffs 28
Johannesburg 28
Orange 28
Zhengzhou 28
Nuremberg 27
Brooklyn 25
Stockholm 23
Denver 22
Washington 22
Auburn Hills 21
Southend 21
Columbus 20
Falls Church 20
Vienna 20
Tokyo 19
Phoenix 18
San Mateo 18
Belo Horizonte 17
Da Nang 17
Ningbo 17
Poplar 17
Sassari 17
Kunming 16
Saint Petersburg 16
Chennai 14
Redmond 12
Tashkent 12
Curitiba 11
Detroit 11
Düsseldorf 11
Guarulhos 11
Mumbai 11
Orem 11
Quito 11
Taizhou 11
Manchester 10
Porto Alegre 10
Totale 285.261
Salva come PNG Salva come JPEG
Nome #
Carbamazepine augmentation in lithium refractory bipolar patients: a prospective study on long-term prophylactic effectiveness 12.090
Leukocyte telomere length positively correlates with duration of lithium treatment in bipolar disorder patients 4.309
Count of “dark telomere” on the track of a biomarker for lithium treatment in bipolar disorder 4.221
Duration of lithium treatment is a risk factor for reduced glomerular function: a cross-sectional study 3.720
Renal function during long-term lithium treatment: a cross-sectional and longitudinal study 3.655
Major depression subtypes are differentially associated with migraine subtype, prevalence and severity 3.595
Whole Genome Expression Analyses of miRNAs and mRNAs Suggest the Involvement of miR-320a and miR-155-3p and their Targeted Genes in Lithium Response in Bipolar Disorder 3.530
A multidisciplinary approach to mental illness: Do inflammation, telomere length and microbiota form a loop? A protocol for a cross-sectional study on the complex relationship between inflammation, telomere length, gut microbiota and psychiatric disorders 3.465
Pharmacogenetics of lithium effects on glomerular function in bipolar disorder patients under chronic lithium treatment: a pilot study 3.460
Continuation versus discontinuation of lithium during pregnancy: a retrospective case series 3.172
An observational study of 110 elderly lithium-treated patients followed up for 6 years with particular reference to renal function 3.133
Differences in telomere length between patients with bipolar disorder and controls are influenced by lithium treatment 3.096
Dopaminergic and serotonergic genes in bipolar disorder: A case control study in a Sardinian population 3.032
Analysis of the influence of microRNAs in lithium response in bipolar disorder 3.022
Evidence towards RNA Binding Motif (RNP1, RRM) Protein 3 (RBM3) as a Potential Biomarker of Lithium Response in Bipolar Disorder Patients 3.002
Preliminary transcriptome analysis in lymphoblasts from cluster headache and bipolar disorder patients implicates dysregulation of circadian and serotonergic genes 2.985
Convergent analysis of genome-wide genotyping and transcriptomic data suggests association of zinc finger genes with lithium response in bipolar disorder 2.976
Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study 2.886
Association of polygenic score for major depression with response to lithium in patients with bipolar disorder 2.864
Exposure and duration of lithium treatment affect leukocyte telomere length in bipolar disorder patients 2.860
Investigating polygenic burden in age at disease onset in bipolar disorder: Findings from an international multicentric study 2.844
Telomere attrition and inflammatory load in severe psychiatric disorders and in response to psychotropic medications 2.826
HDAC3 role in medication consumption in medication overuse headache patients: a pilot study 2.796
Involvement of core clock genes in lithium response 2.776
Differential effect of lithium on spermidine/spermine N1-acetiltransferase expression in suicidal behaviour 2.710
Association of polygenic score for schizophrenia and HLA antigen and inflammation genes with response to lithium in bipolar affective disorder. A genome-wide association study 2.676
Understanding the molecular mechanisms underlying mood stabilizer treatments in bipolar disorder: potential involvement of epigenetics 2.643
Insulin-like growth factor 1 (IGF-1) expression is up-regulated in lymphoblastoid cell lines of lithium responsive bipolar disorder patients 2.641
C9ORF72 repeat expansion and bipolar disorder–is there a link? No mutation detected in a Sardinian cohort of patients with bipolar disorder 2.633
Genome-wide association study of 40,000 individuals identifies two novel loci associated with bipolar disorder 2.627
Increasing engagement in pharmacology and pharmacogenetics education using games and online resources: the PharmacoloGenius mobile app 2.610
Interstitial lung disease induced by fluoxetine: Systematic review of literature and analysis of Vigiaccess, Eudravigilance and a national pharmacovigilance database. 2.565
Online information seeking by patients with bipolar disorder: results from an international multisite survey 2.554
null 2.498
Prediction of Lithium Response using Clinical Data 2.449
High leptin levels are associated with migraine with aura 2.437
Genome-scan for bipolar disorder with sib-pair families in the Sardinian population: a new susceptibility locus on chromosome 1p22-p21? 2.425
Pharmacogenomics of mood stabilizers in the treatment of bipolar disorder 2.408
Novel integrative genomic tool for interrogating lithium response in bipolar disorder 2.393
Pharmacogenomics of bipolar disorder 2.356
Association study in three different populations between the GPR88 gene and major psychoses 2.332
No association of endocannabinoid genes with bipolar disorder or lithium response in a Sardinian sample 2.325
Internet use by patients with bipolar disorder: Results from an international multisite survey 2.297
Fifteen-year follow-up of thyroid function in lithium patients 2.280
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing 2.272
Cellular models to study bipolar disorder: a systematic review 2.141
Exemplar scoring identifies genetically separable phenotypes of lithium responsive bipolar disorder 2.141
Age at onset in bipolar disorder: investigation of the role of TaqIA polymorphism of DRD2 gene in a Sardinian sample 2.120
Solar insolation in springtime influences age of onset of bipolar I disorder 2.097
Lithium-induced differential expression of SAT1 in suicide completers and controls is not correlated with polymorphisms in the promoter region of the gene 2.077
557. Pharmacogenetic Association of Lithium Treatment Response with Bcl2 Polymorphism in Bipolar Disorder 2.047
Association between solar insolation and a history of suicide attempts in bipolar I disorder 2.036
Convergent genetic and expression data implicate immunity in Alzheimer's disease 1.995
null 1.980
Characterisation of age and polarity at onset in bipolar disorder 1.971
Long term lithium treatment and survival from external causes including suicide 1.958
Internet use by older adults with bipolar disorder: international survey results 1.939
Assessment of response to lithium maintenance treatment in bipolar disorder: A Consortium on Lithium Genetics (ConLiGen) report 1.934
MicroRNA expression profiling of lymphoblasts from bipolar disorder patients who died by suicide, pathway analysis and integration with postmortem brain findings 1.900
Clinical factors associated with lithium treatment response in bipolar disorder patients from India 1.860
null 1.842
A genetic risk score is differentially associated with migraine with and without aura 1.817
The international consortium on lithium genetics (ConLiGen): An initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment 1.750
No evidence of association between dopamine D3 receptor gene and bipolar affective disorder 1.735
Value of thyroid echography in the long-term follow-up of lithium-treated patients 1.716
Evidence that genes involved in hedgehog signaling are associated with both bipolar disorder and high BMI 1.695
A European spectrum of pharmacogenomic biomarkers: Implications for clinical pharmacogenomics 1.635
A retrospective case series of bipolar patients with adjunctive carbamazepine in long-term lithium treatment: evaluation of the effectiveness 1.613
Admixture analysis of age at onset in bipolar disorder 1.605
Prediction of lithium response using genomic data 1.602
Insulin-like growth factor 1 differentially affects lithium sensitivity of lymphoblastoid cell lines from lithium responder and non-responder bipolar disorder patients 1.571
Haplotype association study between DRD1 gene and bipolar type I affective disorder in two samples from Canada and Sardinia 1.569
Farmaci per il trattamento delle cefalee primitive e per il controllo del vomito 1.556
Clozapine toxicity due to a multiple drug interaction: a case report 1.534
null 1.525
Influence of light exposure during early life on the age of onset of bipolar disorder 1.459
null 1.449
null 1.424
null 1.414
Genetic linkage and association studies in affective disorders 1.379
Relationship between sunlight and the age of onset of bipolar disorder: an international multisite study 1.368
A case-control association study of the PDLIM5 gene and bipolar disorder in a Sardinian sample 1.367
null 1.334
Association study between the phenotype migraine without aura-panic disorder and dopaminergic receptor genes 1.326
Age at Onset in Sardinian Bipolar I Patients: Evidence for Three Subgroups 1.283
Influence of birth cohort on age of onset cluster analysis in bipolar I disorder 1.247
Six-year follow-up of thyroid function during lithium treatment 1.229
Investigation of endocannabinoid system genes suggests association between peroxisome proliferator activator receptor-α gene (PPARA) and schizophrenia 1.225
Interacting genes in lithium prophylaxis: preliminary results of an exploratory analysis on the role of DGKH and NR1D1 gene polymorphisms in 199 Sardinian bipolar patiens 1.210
Protocol for a pharmacogenetic study of antidepressants: characterization of drug-metabolizing profiles of cytochromes CYP2D6 and CYP2C19 in a Sardinian population of patients with major depressive disorder 1.209
Association of personal and familial suicide risk with low serum cholesterol concentration in male lithium patients 1.198
Investigation of genetic loci shared between bipolar disorder and risk-taking propensity: potential implications for pharmacological interventions 1.197
A48G polymorphism in the D1 receptor genes associated with bipolar I disorder 1.178
Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations. 1.172
Thyroid abnormalities during lithium treatment 1.170
A Protective HLA Extended Haplotype Outweighs the Major COVID-19 Risk Factor Inherited From Neanderthals in the Sardinian Population 1.163
null 1.161
Evaluation of lithium response in episodic cluster headache: a retrospective case series 1.157
null 1.146
Association of Attention-Deficit/Hyperactivity Disorder and Depression Polygenic Scores with Lithium Response: A Consortium for Lithium Genetics Study 1.134
Totale 225.006
Salva come PNG Salva come JPEG
Categoria #
all - tutte 368.416
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 368.416
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202128.000 0 0 0 0 0 7.632 5.431 4.546 1.576 3.262 3.433 2.120
2021/202214.194 1.828 1.069 802 973 1.113 903 1.028 822 1.259 1.390 1.580 1.427
2022/202320.690 1.579 2.881 2.643 1.777 1.670 2.293 887 1.674 1.569 1.324 1.592 801
2023/202420.950 1.043 1.047 885 1.700 1.899 3.489 2.967 1.300 908 1.333 2.379 2.000
2024/202576.726 26.215 24.066 9.999 4.266 2.622 2.549 3.955 259 520 1.409 400 466
2025/20264.977 765 472 1.451 1.141 1.004 144 0 0 0 0 0 0
Totale 293.348